Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
SLAT regulates Th1 and Th2 inflammatory responses by controlling Ca2+/NFAT signaling
Stéphane Bécart, … , Michael Croft, Amnon Altman
Stéphane Bécart, … , Michael Croft, Amnon Altman
Published August 1, 2007
Citation Information: J Clin Invest. 2007;117(8):2164-2175. https://doi.org/10.1172/JCI31640.
View: Text | PDF
Research Article Immunology

SLAT regulates Th1 and Th2 inflammatory responses by controlling Ca2+/NFAT signaling

  • Text
  • PDF
Abstract

SWAP-70–like adapter of T cells (SLAT) is a novel guanine nucleotide exchange factor for Rho GTPases that is upregulated in Th2 cells, but whose physiological function is unclear. We show that SLAT–/– mice displayed a developmental defect at one of the earliest stages of thymocyte differentiation, the double-negative 1 (DN1) stage, leading to decreased peripheral T cell numbers. SLAT–/– peripheral CD4+ T cells demonstrated impaired TCR/CD28-induced proliferation and IL-2 production, which was rescued by the addition of exogenous IL-2. Importantly, SLAT–/– mice were grossly impaired in their ability to mount not only Th2, but also Th1-mediated lung inflammatory responses, as evidenced by reduced airway neutrophilia and eosinophilia, respectively. Levels of Th1 and Th2 cytokine in the lungs were also markedly reduced, paralleling the reduction in pulmonary inflammation. This defect in mounting Th1/Th2 responses, which was also evident in vitro, was traced to a severe reduction in Ca2+ mobilization from ER stores, which consequently led to defective TCR/CD28-induced translocation of nuclear factor of activated T cells 1/2 (NFATc1/2). Thus, SLAT is required for thymic DN1 cell expansion, T cell activation, and Th1 and Th2 inflammatory responses.

Authors

Stéphane Bécart, Céline Charvet, Ann J. Canonigo Balancio, Carl De Trez, Yoshihiko Tanaka, Wei Duan, Carl Ware, Michael Croft, Amnon Altman

×

Figure 2

Thymocyte development in SLAT–/– mice.

Options: View larger image (or click on image) Download as PowerPoint
Thymocyte development in SLAT–/– mice.
               
(A) Representativ...
(A) Representative thymi from 8-week-old control WT or SLAT–/– mice (left); total thymocyte cell numbers from individual mice were determined (right). Lines indicate the mean, and each symbol represents an individual mouse. (B) Sections of thymi from WT (left) or SLAT–/– (right) mice were stained with anti-CD4 (blue) and anti-CD8 (red) mAbs. Thymic medulla (me) and cortex (co) areas are indicated. (C) Total thymocytes from 8-week-old WT and SLAT–/– mice were analyzed by flow cytometry for CD4 and CD8 expression. The percentage (mean ± SD) of each subpopulation (n = 10) is shown in each quadrant. (D) Numbers of thymocyte subpopulations in WT mice and SLAT–/– mice were calculated. (E) DN thymocytes were gated as described in Methods and analyzed for CD44 and CD25 expression. The percentage (mean ± SD) of each subpopulation (n = 8) is shown. (F) Numbers of DN thymocyte subpopulations in WT and SLAT–/– mice were calculated. (G and H) Eight-week-old WT and SLAT–/– mice (n = 4) were injected i.p. daily for 3 or 6 days with BrdU (1 mg/ml). On days 4 or 7, respectively, the percentage of BrdU+ DN, DP, CD4+ SP, and CD8+ SP (G) and the percentage of BrdU+ DN subpopulations in DN-gated thymocytes (H) were analyzed. Results are expressed as mean ± SD. Statistical differences were determined using 2-tailed Student’s t test. *P < 0.05, **P < 0.01, #P < 0.001, WT versus SLAT–/– mice.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts